Bilal Arif - Net Worth and Insider Trading

Bilal Arif Net Worth

The estimated net worth of Bilal Arif is at least $2 Million dollars as of 2025-01-12. Bilal Arif is the Chief Tech Ops Officer of Sarepta Therapeutics Inc and owns about 17,363 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $2 Million. Details can be seen in Bilal Arif's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bilal Arif has not made any transactions after 2024-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bilal Arif

To

Bilal Arif Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bilal Arif owns 1 companies in total, including Sarepta Therapeutics Inc (SRPT) .

Click here to see the complete history of Bilal Arif’s form 4 insider trades.

Insider Ownership Summary of Bilal Arif

Ticker Comapny Transaction Date Type of Owner
SRPT Sarepta Therapeutics Inc 2024-06-25 Chief Tech Ops Officer

Bilal Arif Latest Holdings Summary

Bilal Arif currently owns a total of 1 stock. Bilal Arif owns 17,363 shares of Sarepta Therapeutics Inc (SRPT) as of June 25, 2024, with a value of $2 Million.

Latest Holdings of Bilal Arif

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2024-06-25 17,363 124.79 2,166,729

Holding Weightings of Bilal Arif


Bilal Arif Form 4 Trading Tracker

According to the SEC Form 4 filings, Bilal Arif has made a total of 2 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 11,757 shares on June 25, 2024, which brought Bilal Arif around $2 Million.

Insider Trading History of Bilal Arif

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bilal Arif Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bilal Arif Ownership Network

Ownership Network List of Bilal Arif

No Data

Ownership Network Relation of Bilal Arif

Insider Network Chart

Bilal Arif Owned Company Details

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Bilal Arif is the Chief Tech Ops Officer of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , SVP & General Counsel Ryan Edward Brown , and director & President & CEO Douglas S Ingram .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Bilal Arif made 2 insider transaction in Sarepta Therapeutics Inc (SRPT) with a net sale of 13,757. Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,500 shares made by Wigzell Hans Lennart Rudolf , and a net sale of 40,957 shares made by Ryan Edward Brown .

In summary, during the past 3 months, insiders sold 12,136 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 12,136 shares. During the past 18 months, 111,566 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 69,229 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sarepta Therapeutics Inc Insider Transactions

No Available Data

Bilal Arif Mailing Address

Above is the net worth, insider trading, and ownership report for Bilal Arif. You might contact Bilal Arif via mailing address: 215 First Street, Cambridge Ma 02129.